Cases involving cirrhosis of the liver by alcohol among British people aged 25-to-34 years have more than doubled during the last decade, figures show.
The Times of London said that recent information presented to Britain's Liberal Democrats showed that between 1996-97 and 2005-06, the number of alcohol-related cirrhosis instances rose from 270 to 642.
During that same time period, the amount of overall cirrhosis cases rose from nearly 7,000 annually to more than 19,000 a year.
Royal College of Physicians President Ian Gilmore said that recent medical findings of increased final-stage cirrhosis in the age group suggest that the negative pattern is likely to rise further in the future.
Such findings prompted Sandra Gidley, the Liberal Democrat health spokeswoman, to criticize the current British healthcare system.
"Ministers should have woken up to this issue and taken action years ago," she told the paper.
Copyright 2007 by United Press International
Related stories:
Study: Dramatic rise in hepatitis C-related deaths in the United States
Hepatitis C-related deaths in the United States increased by 123 percent from 1995 through 2004, the most recent year for which data are available. Mortality rates peaked in 2002, then declined slightly overall, while continuing to rise among people 55 to 64 years old. These findings appear in the April issue of
Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD).
Light wine intake is associated with longer life expectancy in men
Drinking a little alcohol every day, especially wine, may be associated with an increase in life expectancy. That’s the conclusion of Dutch researchers who reported the findings of their study today at the American Heart Association’s 47th Annual Conference on Cardiovascular Disease Epidemiology and Prevention.
Resveratrol prevents fat accumulation in livers of 'alcoholic' mice
The accumulation of fat in the liver as a result of chronic alcohol consumption could be prevented by consuming resveratrol, according to a new study with mice. The research found that resveratrol reduced the amount of fat produced in the liver of mice fed alcohol and, at the same time, increased the rate at which fat within the liver is broken down.
Gene variant boosts risk of fatty liver disease, scientists discover
Researchers at UT Southwestern Medical Center have found that individuals who carry a specific form of the gene PNPLA3 have more fat in their livers and a greater risk of developing liver inflammation. They also found that Hispanics are more likely to carry the gene variant responsible for higher liver-fat content than African-Americans and Caucasians.
People with type 2 diabetes can put fatty livers on a diet with moderate exercise
Weekly bouts of moderate aerobic exercise on a bike or treadmill, or a brisk walk, combined with some weightlifting, may cut down levels of fat in the liver by up to 40 percent in people with type 2 diabetes, a study by physical fitness experts at Johns Hopkins shows.
Senescence in liver cells can provoke a beneficial immune reaction
Although post-reproductive life in humans is often associated with decline and a loss of powers, an analogous state in certain cells -- called senescence -- is proving to be one of ironic potency. Scientists at Cold Spring Harbor Laboratory (CSHL) today reported that a particular class of senescent liver cells orchestrates a sequence of events in living mice that can limit fibrosis, a natural response of the liver to acute damage.
To protect against liver disease, body puts cells 'under arrest'
A stable form of cell-cycle arrest known to offer potent protection against cancer also limits liver fibrosis, a condition characterized by an excess of fibrous tissue, according to a new report in the August 22nd
Cell, a Cell Press publication. Triggered by chronic liver damage produced by hepatitis infection, alcohol abuse, or fatty liver disease, liver fibrosis can lead to cirrhosis, a major health problem worldwide and the 12th most common cause of death in the United States.
Early treatment is key to combating hepatitis C virus
Canadian researchers have shown that patients who receive early treatment for Hepatitis C virus (HCV) within the first months following an infection, develop a rapid poly-functional immune response against HCV similar to when infection is erradicted spontaneously, according to a new study published in the
Journal of Virology. Therefore, early treatment can restore immune response against HCV and help eliminate the virus rapidly. This new discovery of the mechanisms of viral eradication could contribute to the development of new treatments.